Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70
(0.87%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s Laboratories launches Doxercalciferol Injection
>>
Dr. Reddy’s Laboratories starts outsourcing manufacture of some of drugs to local partners
>>
Dr. Reddy’s Laboratories launches diabetes nutrition drink ‘Celevida’ in India
>>
Dr Reddy’s Laboratories wins ‘API Supplier of the Year’ award
>>
Dr. Reddy's Laboratories slips despite reporting over 2-fold jump in Q2 consolidated net profit
>>
Dr. Reddy's Laboratories reports over 2-fold jump in Q2 consolidated net profit
>>
USFDA completes inspection at Dr. Reddy's Lab’s API Srikakulam plant
>>
Dr. Reddy's Lab gets EIR for Formulations Manufacturing facility at USA
>>
Dr. Reddy's Lab confirms its voluntary nationwide recall of all Ranitidine products in US
>>
Dr. Reddy's Lab gains on getting EIR for API manufacturing at Hyderabad
<<
<
63
64
65
...145
>
>>